Product Details
Product Name:
ORM-13070 |
CAS No.:
1227170-43-5 |
Supply Ability:
10g |
Release date:
2025/04/29 |
Product Introduction
Bioactivity
Name | ORM-13070 |
Description | ORM-13070 is a selective antagonist radioligand for the α2C adrenoceptor subtype. ORM-13070 C-11 is under investigation in clinical trial. |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Keywords | ORM-13070 | ORM13070 | ORM 13070 | LY-2780301 | LY 2780301 |
Company Profile Introduction
TargetMol Chemicals Inc. is headquartered in Boston, MA, and specializes in products and services that serve the research needs of chemical and biological scientists worldwide. With a client base in 40+ countries, TargetMol has evolved into one of the biggest global research suppliers for compound libraries and small molecule compounds.
170+ Compound Libraries, 10000+ Noval Small Molecucles,16000+ Nature Compounds
TargetMol diligently updates and offers over 170 types of compound libraries and a wide range of high-quality research chemicals, including inhibitors, activators, natural products, peptides, antibodies , and novel life-science kits for laboratory and scientific use. In addition, our lab allows us to conduct CADD (computer-aided drug design) and chemical synthesis to meet the customization needs of our clients.
You may like
-
CAS:360794-85-0
$1520.00 / 25mg
-
CAS:1309859-14-0
$1520.00 / 25mg
Recommended supplier
Product name |
Price |
|
Suppliers |
Update time |
|
$139.00/5mg |
VIP5Y
|
TargetMol Chemicals Inc.
|
2025-05-26 |
|
$0.00/25kg |
VIP1Y
|
Shaanxi Dideu New Materials Co. Ltd
|
2025-03-08 |
|
$2500.00/100mg |
VIP3Y
|
TargetMol Chemicals Inc.
|
2024-10-28 |